GlassScriptPhysician profile
Michael F Walker
NPI 1659378842
$14,441.45
in general payments reported to CMS, 2019-2025
50 companies · $2,737 in 2025
The $2,737 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,908 · 2020: $827 · 2021: $1,175 · 2022: $2,390 · 2023: $2,385 · 2024: $2,018 · 2025: $2,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,096 · Education: $36.32 · Travel and Lodging: $8.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,096.35 |
| Education | $36.32 |
| Travel and Lodging | $8.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,334.38 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,855.23 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $1,237.18 | 2019-2025 | Evenity, Prolia, Tepezza |
| Insulet Corporation | $990.19 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $935.47 | 2019-2025 | |
| Abbott Laboratories | $884.64 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $765.35 | 2019-2025 | Farxiga, Lokelma |
| Mannkind Corporation | $603.64 | 2019-2025 | Afrezza |
| Dexcom, INC. | $552.40 | 2019-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $452.59 | 2019-2025 | Synthroid, Dalvance |
| Radius Health, INC. | $441.89 | 2019-2025 | Tymlos |
| Corcept Therapeutics | $346.99 | 2019-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.10 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $264.69 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $237.17 | 2019-2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $229.48 | 2024-2025 | Yorvipath |
| Medtronic, INC. | $206.64 | 2022-2023 | Minimed 780g |
| Alexion Pharmaceuticals, INC. | $183.78 | 2020-2024 | Strensiq |
| Merck Sharp & Dohme LLC | $140.31 | 2019-2023 | Steglatro, Steglujan |
| Recordati_rare_diseases_inc. | $120.29 | 2022-2025 | Isturisa, Signifor Lar |
| Ibsa Pharma INC. | $119.43 | 2019-2025 | Licart, Tirosint, Flector |
| Tandem Diabetes Care, INC. | $103.34 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novartis Pharmaceuticals Corporation | $99.81 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $89.89 | 2021-2023 | Unithroid |
| Ipsen Biopharmaceuticals, INC | $83.66 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $80.80 | 2022-2023 | Gvoke Hypopen |
| Tolmar, INC. | $75.27 | 2023-2025 | Jatenzo |
| Opko Pharmaceuticals, LLC | $54.61 | 2022-2023 | Rayaldee |
| Rhythm Pharmaceuticals, INC. | $53.05 | 2023-2025 | Imcivree, Imcivree |
| Madrigal Pharmaceuticals | $50.55 | 2025 | Rezdiffra |
| Embecta Corp. | $44.51 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amarin Pharma, INC. | $44.28 | 2019 | |
| Alnylam Pharmaceuticals INC. | $43.08 | 2024-2025 | Givlaari |
| Janssen Scientific Affairs, LLC | $40.24 | 2019-2020 | |
| Becton, Dickinson and Company | $38.41 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $36.64 | 2019 | |
| Pfizer INC. | $36.03 | 2023 | |
| Averitas Pharma INC. | $32.97 | 2024-2025 | Qutenza |
| Neurocrine Biosciences, INC. | $30.95 | 2025 | |
| Lifescan, INC. | $30.78 | 2020 | |
| Esperion Therapeutics, INC. | $30.72 | 2021 | |
| Antares Pharma, INC. | $26.82 | 2019 | |
| Ascensia Diabetes Care US INC. | $25.39 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $20.43 | 2019 | |
| Rgh Enterprises LLC | $19.34 | 2024 | |
| Bigfoot Biomedical INC | $18.71 | 2022 | |
| Beta Bionics, INC. | $18.28 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Arbor Pharmaceuticals, INC. | $13.82 | 2019 | |
| Eusa Pharma (US) LLC | $13.50 | 2022 | |
| Amryt Pharma Holdings LTD | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.